Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
Details for Australian Patent Application No. 2002255961 (hide)
International Classifications
Event Publications
3 April 2003 Application Open to Public Inspection
Published as AU-B-2002255961
8 June 2006 Assignment before Grant
The Picower Institute for Medical Research The application has been assigned to Cytokine PharmaSciences, Inc
26 July 2007 Amendment Made
The nature of the amendment is: Delete co-inventors Donnelly, Seamas and Mitchell, Robert.
23 August 2007 Application Accepted
Published as AU-B-2002255961
20 December 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002255962-METHOD AND APPARATUS FOR DELIVERING MESSAGES TO WIRELESS DEVICES
2002255960-Hand-held surgical instruments with omni-circumferential actuation capabilities
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser